retatrutide weight loss clinical trials Trial of next-gen weight-loss drug brings it one step closer to FDA approval Phase III retatrutide study demonstrates

You may find taking a number of vitamin supplements beneficial during your bioidentical hormone replacement treatment

No Shortcuts

Decreased SIRT1 expression in colon epithelial cells of UC patients and DSS-induced mice correlates with immune dysregulation (Caruso et al., 2014

This may be more common in patients who: are under-eating recently lost significant weight have poor protein intake are combining multiple wellness therapies simultaneously Injection Site Reactions Because many peptide therapies are injectable, patients may occasionally notice: redness swelling itching bruising tenderness Injection technique and sterile handling matter significantly

Patients should carefully follow provider instructions and ask for demonstrations if needed

It is not FDA approved, it is not EMA approved, and all current use remains strictly research-use-only